ARCHIVES

Hormonal Therapy Improves Prostate Cancer Survival

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999